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Abstract
Background/Aims: FSH receptor (FSHR) Ala307Thr and Asn680Ser and LHβ chain (LHB) 
Trp28Arg and Ile35Thr polymorphisms affect the response to pharmacological ovarian 
stimulation with r-FSH in women undergoing assisted reproductive treatment (ART). Here, 
we evaluated the expression level of selected genes involved in follicle maturation and the 
possible onset of apoptosis in cumulus cells of patients with single and double FSHR and 
LHB polymorphisms, as potential markers of oocyte competence. Methods: Cumulus cells 
from 36 stimulated patients were collected and SNP genotyping performed by PCR. Gene 
expression was evaluated through real-time PCR, and apoptosis estimated via TUNEL assay, 
and cleaved caspase-3 and pAKT immunostaining. Results: The cumulative data show 
significant correlations indicating that the genetic alteration of FSHR and/or LHB genes may 
lead to perturbations of the signaling network programmed to granulosa cell survival and 
follicle development. Notably, when double heterozygotes were compared to the rest of the 
patients, a higher level of apoptosis in terms of both DNA fragmentation index and amount 
of active caspase-3 was observed in cumulus cells. Conclusions: These results may help to 
define personalized stimulation protocols in ART programs, to increase the success rate of ICSI 
procedures in accordance with the polymorphic condition of the individual patient.
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Introduction
It is well-known that gonadotropins are key protagonists in folliculogenesis and specific 
polymorphisms of the genes encoding for such hormones and their receptors may influence the growth of follicles and oocytes, also in relation to the pharmacological stimulation of ovulation. Some polymorphisms of the receptors for FSH (FSHR) and of the β subunit of LH (LHB) have been extensively studied [1] and, in some cases, it was possible to establish that the 
presence of specific allelic combinations should be taken into consideration for personalized 
stimulation protocol [2, 3]. Regarding FSHR, the Ala307Thr (A307T) and Asn680Ser 
(N680S) polymorphisms located in exon 10 and resulting in aminoacidic substitutions in 
the intracellular FSH binding- and extracellular adenylate cyclase coupling domains of the 
receptor, respectively, are the most commonly found. Being in linkage disequilibrium, these 
polymorphisms may give rise to two different combinations of receptor isoforms, i.e. A/S and 
T/N [4].  Previous studies demonstrated a prominent interrelation between FSHR genotype 
and FSH-induced ovarian response, which may affect the efficacy of the stimulation protocol. 
As an example, in vitro fertilization (IVF) patients, in the case of S/S combination, show both 
an increased FSH baseline level and a resistance for ovarian stimulation thereby needing a 
higher amount of FSH administration or a higher starting dose [5].
Also the LHB variants appear to regulate the follicular growth and maturation. It is 
known that LH-triggered up-regulation of androgens may influence follicular metabolism 
promoting the acquisition of FSH sensitivity [6]. The two more studied polymorphisms of 
LHB are represented by the missense nucleotide substitutions in exon 2 Trp28Arg (W28R) 
and Ile35Thr (I35T), which are often found to occur concurrently, that generate an extra 
glycosylation signal in the protein subunit thereby affecting protein folding and hormonal 
activity [7]. Owing to the lower bioactivity of mutated LH, the carriers of such polymorphic variant of LHB, named v-βLH, necessitate higher r-FSH administration during controlled 
ovarian stimulation [8]. No studies have been designed so far relating the polymorphic 
variants of FSHR and LHB with oocyte competence.
The efficacy of IVF treatments is evaluated considering the rate of healthy children 
born, nonetheless reproductive biology provides diverse means to estimate the comparative 
success of an IVF protocol. Among the non-invasive tools, it is possible to include specific assays on cumulus cells; these cells are in close molecular communication with the female 
gamete and therefore represent an interesting investigative instrument in embryology [9]. 
Both the expression levels of some components of intracellular survival pathways and the 
apoptosis rate can be assessed in cumulus cells and utilized as potential markers of oocyte 
competence. The amounts of the mRNAs for the epidermal growth factor (EGF)-like factors 
amphiregulin (AREG) and epiregulin (EREG) have been shown to increase in gonadotropin 
(especially LH)-treated primary human granulosa cells [10]. The protein products, once 
released from the cell membrane by proteolysis, can bind the EGF receptor (EGFR) and induce 
cumulus expansion and oocyte maturation via mitogen-activated protein kinases (MAPK)-1 
and -3 pathways [11, 12]. Also, EGFR expression levels have been correlated to the maturative 
capacity of oocytes [13]. In addition, the expression levels of gonadotropin receptors such 
as FSHR and luteinizing hormone/human chorionic gonadotropin receptor (LHCGR), the 
latter being an adenylate cyclase activator, have been proven to regulate key events such as follicular growth, dehiscence and the activity of corpus luteum via promotion of EGF-
like factor accumulation [12, 14]. Among the molecules implicated in signal transduction, 
phospho-AKT (pAKT) is a well-known activated serine/threonine kinase involved not only 
in life/death decisions but also in the control of metabolism and differentiation, as shown 
in both normal and pathologic cell systems (e.g  [15, 16]). In the ovary, it is known that Kit .ligand induces maintenance of primordial follicular pools via phosphatidylinositol 3-kinase 
(PI3K)/Akt signalization, whereas Phosphatase and Tensin Homolog (PTEN)-induced Akt 
dephosphorylation in granulosa cells can be observed during terminal follicular growth [17, 
18].
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Concerning the evaluation of the onset of apoptosis, the terminal deoxynucleotidyl 
transferase (TdT) dUTP nick-end labeling (TUNEL) assay, which provides information on 
DNA fragmentation at single cell level [19], has been widely used to quantitate the number of 
apoptotic cells, including those present in oocyte, cumulus cell, and spermatozoa preparations 
[20-23]. This analysis has been also supplemented by parallel immunohistochemistry with 
anti-cleaved caspase-3, thereby evaluating the extent of activation of the ubiquitously-
expressed “effector” enzyme, which is a widely-acknowledged sensitive tool for the in situ 
detection of apoptotic [24].
In this study, we wanted to check whether a correlation exists in the extent of gene 
expression and/or apoptosis markers from cumulus cells of oocytes among patients with 
specific gonadotropin polymorphisms, after ovarian stimulation with r-FSH. Our work 
hypothesis is that the presence of specific polymorphisms of FSHR and LHB genes might 
be reflected in an alteration of specific pathways influencing the oocyte competence. In 
particular, the following four SNPs have been taken into consideration: for FSHR, those 
identified as A307T and N680S; for LHB, those identified as W28R and I35T.
Materials and Methods
Study design and patients
A longitudinal, prospective clinical trial was carried out in three assisted reproductive treatment (ART) 
Centres in Italy (Palermo, Siena and Bari).
Thirty-six women attending the ART clinic because of fertility problems, were consecutively recruited 
according to the following inclusion and exclusion criteria. The inclusion criteria were: age < 38 years, 
normal FSH basal level (<12 UI/mL), body mass index (BMI) <28 kg/m2, normoresponder patients with a 
minimum of 6 oocytes collected at pick-up. Only one inclusion criterion for the male partner was provided, 
i.e. a motile sperm count higher than 4x106 per ejaculate. Women who underwent multiple attempts of 
assisted reproduction were included in the study. The occurrence of endometriosis, even if non-overt, in 
r-FSH-treated women was considered as an exclusion criterion. Such inclusion and exclusion criteria were 
chosen to minimize bias and help ensure the comparability of the individuals analyzed, so that the results of 
our study may be related mostly to polymorphism-related conditions.
Ovarian stimulation
All women recruited were similarly treated with a GnRH agonist Buserelin (Suprefact, Sanofi-Aventis, 
Italy, 0.2 ml/day) administration, starting on day 21 of the previous cycle. Administration of 150–225 IU 
r-FSH/day (Gonal-f, Merck, Rome, Italy) was started at day 8 after GnRH agonist treatment and the follicular 
growth was monitored every two days using ultrasound and serum estradiol E2 levels, starting on day 6 of stimulation, modifying the dose of r-FSH as a consequence. The dose of 10, 000 IU of hCG (Ovitrelle; Merck, 
Rome, Italy) was administered when at least 3 follicles showed a diameter ≥ 18 mm.
Extraction of genomic DNA and genotyping of FSHR and LHB single nucleotide polymorphisms (SNPs)
Genomic DNA was obtained from samples of whole blood with MagNA LC 2.0 instrument (Roche, 
Monza, Italy). The genotyping of SNPs was performed by PCR amplification in the presence of 250 nM 
of each primer, 2.5 U of AmpliTaq Gold DNA polymerase and 180 ng DNA in an Applied Biosystem 2720 
thermocycler (Life Technologies). The PCR primers were designed using the Primer3 software available at 
http://biotools.umassmed.edu/bioapps/primer3_www.cgi.
The primers used for detection of rs6165 (polymorphism A307T) and rs6166 (polymorphism 
N680S) FSHR SNPs were: FSHR_A307T_F (5’-AAGCAGCATTAACCCTTGAG-3’), FSHR_A307T_R 
(5’-TCTTCACATGGGTTGAATGC-3’), FSHR_N680S_F (5’-ATTTCTGCCTCCCTCAAGGT-3’) and FSHR_N680S_R 
(5’-GAAGCACTGTCAGCTCTTTGTG-3’). The expected sizes of the two amplification products were 427 e 
440 bp, respectively. The primers used for detection of rs1800447 (polymorphism W28R) and rs34349826 
(polymorphism I35T) LHB SNPs were LHB_EX2_F (5’-AGGGTGGGGATCTGAAATG-3’) and LHB_EX2_R 
(5’-TGAGCTCCCAAGCTGACC-3’). The expected size of the amplification product was 557 bp. Thermocycler 
conditions were as follows: 94° C for 8 min., 2 cycles of 94° C for 1 min., 55° C for 1 min. and 72° C for 1 min., 
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33 cycles of 94° C for 30 sec., 55° C for 30 sec. and 72° C for 30 sec., with a final extension at 72° C for 7 min. 
The PCR products were visualized on a 2% agarose gel stained with 50 µg/ml of ethidium bromide under 
UV light and their size compared with a 100 bp DNA ladder (Invitrogen).
For restriction fragment length polymorphism (RFLP) analysis, the amplification products were 
digested with Fermentas FastDigest restriction enzymes as follows: FSHR-A307T with Eam1105I (37°C, 1 h.); FSHR-N680S with BseNI (65°C, 1 h.); LHB-Ex2 with NcoI (37°C ,1 h.) to detect W28R polymorphism and with FokI (37°C, 1 h.) to detect I35T polymorphism. The digestion products were checked by 2% agarose 
electrophoresis and ethidium bromide stain and their size compared with a 100 bp DNA ladder (Invitrogen). 
The digestion patterns of the different restriction assays were as follows: (i) FSHR-A307T/Eam1105I: 285 
bp + 138 bp for A/A genotype; 254 bp + 138 bp + 31 bp for T/T genotype and 285 bp + 254 bp + 138 bp + 31 
bp for A/T genotype. (ii) FSHR-N680S/BseNI: 279 bp + 157 bp for S/S genotype; 440 bp for N/N genotype 
and 440 bp + 279 bp + 157 bp for S/N genotype. (iii) LHB-W28R/NcoI: 275 bp + 182 bp + 100 bp for W/W 
genotype; 375 bp + 182 bp for R/R genotype and 375 bp + 275 bp + 182 bp + 100 bp for W/R genotype. (iv) 
LHB-I35T/FokI: 273 bp + 160 bp + 81 bp + 43 bp for I/I genotype; 316 bp + 160 bp + 81 bp for T/T genotype 
and 316 bp + 273 bp + 160 bp + 81 bp + 43 bp for I/T genotype.
The PCR fragments were also be checked by modified Sanger’s sequencing reactions to ensure the 
correct match between genotype and RFLP.
Preparation of cumulus cells
Sample preparation was performed as reported by [20]. Briefly, after ovum pick-up, the cumulus-oocyte 
complexes were incubated with 80 IU hyaluronidase/ml (Medicult, Jyllinge, Denmark; Irvine Scientific, 
California, USA) for 1 min and cumulus cells were then mechanically released by gently pipetting with a 
170 micron denuding pipette. Cumulus cells, deriving from the patient-specific pool of available COCs, were 
divided into two parts: one was transferred in a 1.5 ml vial containing 500 µl of TRI reagent™  (Sigma, 
St.Louis, MO/USA) and stocked at -80°C for gene expression analysis, whereas the other was collected 
in a test tube (Falcon, Franklin Lakes, NJ) containing 2 mL of medium with HEPES (SAGE IVF, Trumbull, 
CT/USA; Irvine Scientific, California, USA) and centrifuged twice for 7 min. at 800 rpm and then fixed in 
3.7% paraformaldehyde for 1 h. Then, cells were centrifuged for 7 min. at 2000 rpm and suspended in 
PBS after the removal of the supernatant. The cytospin method was used to mount cells on polylysine-coated glass slides to perform in situ immunocytochemistry and TUNEL assay. Oocytes were transferred to 
fertilization medium (SAGE IVF; Irvine Scientific, California, USA) and incubated at 37°C and 6% CO
2
, until 
intracytoplasmic sperm injection (ICSI).
Gene expression assay
RNA extraction was performed with TRI reagent™ according to manufacturer’s instructions starting 
from 500 μl thawed aliquots and resuspending extracted RNA in 25 μl of diethyl pyrocarbonate (DEPC)-
treated water. One µg of RNA was reverse transcribed with the GoScript Reverse Trascription System 
(Promega Italia, Milan, Italy) according to manufacturer’s instructions and gene expression analysis was 
performed using Real-time PCR. Briefly, a protocol with TaqMan® Gene Expression Master Mix and Assay 
on Demand on a 7700 Real-time PCR System (Applied Biosystems Italia, Monza, Italy) was used with the 
following cycle characteristics: 2 minutes at 50°C, 10 minutes at 95°C and 40 cycles with 15 second at 95°C 
and 1 minutes at 60°C. The expression levels of LHCGR (Hs00896336_m1), FSHR (Hs00174865_m1), EREG 
(Hs00914313_m1), EGFR (Hs01076078_m1), AREG (Hs00950669_m1) and HPRT1 (Hs99999909_m1) 
genes, the latter as endogenous control, were investigated. Data were analyzed using the comparative Ct 
method, where Ct is defined as the cycle number in which fluorescence first crosses the threshold. ΔCt was 
found by subtracting the endogenous gene Ct values from the values of the target genes. The result was 
applied to the term 2(-ΔCt). The personnel involved in the procedure were blinded to the IVF treatment and genetic analyses outcomes.
Fluorescent in situ TUNEL assay
In order to assess the extent of DNA apoptotic fragmentation [25], cumulus cells were washed 
in PBS and permeabilized at 4°C in 0.1% Triton X100 plus 0.1% sodium-citrate in PBS at 4°C, and then 
washed three times in PBS at room temperature. Subsequently, cells were incubated for 60 min. at 37°C 
in a humidified chamber in 50 µl of a mixture containing 5 µl of nucleotide mix, 1 µl of TdT enzyme, and 
45 µl of equilibration buffer (DeadEndFluorometric TUNEL System, Promega Italia, Milan, Italy). Negative 
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control was made by incubating the cells with the same mixture without the TdT enzyme, whereas positive 
control another by treating cells briefly with 10 U/ml DNAse I. The reaction was blocked with SSC, followed 
by exhaustive washing in PBS. The cumulus cells were counterstained with propidium iodide (1µg/ml) 
and observed under an Olympus BX 50 microscope equipped with a reflected light fluorescent attachment 
(Olympus), and a 20× 0.40 objective.
Immunofluorescence in situ assays
For immunodetection, cells were washed in PBS and permeabilized for 10 minutes at 4°C in a solution of 
0.1% Triton X-100 plus 0.1% sodium citrate in PBS. Then, cells were washed three times in PBS and incubated 
overnight at 4°C with anti-pAKT polyclonal antibody (1:50 dilution, Santa Cruz Biotechnology, Santa Cruz, 
CA, USA), and anti-cleaved caspase-3 polyclonal antibody (1:50 dilution, Cell Signaling Technology, Danvers, 
MA/USA) dissolved in 3% BSA in PBS. The primary antibody was omitted in negative controls. After three 
rinses with PBS, incubation with the secondary antibody, anti-rabbit IgG (whole molecule) F(ab)
2
 fragment-
Cy3 (1:50 dilution, Sigma), was performed for 1 h. The cumulus cells were counterstained for 10 min. 
with Hoechst 33342 (Invitrogen), mounted in 10 μl DABCO solution (deionized H
2
O, 1 M Tris-HCl pH 8, 2 
mM DABCO, glycerol) and observed under an Olympus BX 50 microscope equipped with a reflected light 
fluorescent attachment (Olympus), and a 20×0.40 objective. Densitometric analysis of fluorescent signals 
was performed using NIS-Elements BR 3.10 image analyzer software (Nikon) as reported by [26].
Statistical Analysis
This is an exploratory analysis and genotype frequencies of SNPs and Hardy-Weinberg equilibrium 
were evaluated by SNPStats software [27] available at http://bioinfo.iconcologia.net/SNPstats.
Each parameter was considered according to genotypes of each SNP evaluated. Kolmogorov-Smirnov 
test was used for evaluation of variable distribution and differences for continuous variables among groups 
were evaluated performing univariate ANOVA, for variables normally distributed, and Kruskal-Wallis or 
Mann-Whitney test for not-normally distributed ones. Dunnet test was used as post-hoc test. Spearman’s 
coefficient regression was selected because the normal distribution of parameters was not requested for 
this evaluation. Moreover, the same analyses were repeated comparing women with SNP heterozygosis on 
both FSHR and LHB with all other women.
Statistical analysis was performed using the ‘Statistical Package for the Social Sciences’ software for 
Macintosh (version 20.0; SPSS Inc., Chicago, IL). Statistical significance was considered for p-values <0.005.
Results
Patients: clinical 
characteristics, r-FSH 
dosage and treatment 
response
Thirty-six women were recruited with a mean age 
of 34.36±2.60 years and a 
mean BMI of 22.05±2.91 
kg/m2. Both age and BMI 
were normally distributed and did not differ among genotypes, considering 
FSHR p.A307T (p=0.384 
and p=0.682, respectively), 
FSHR p.N680S (p=0.384 
and p=0.682, respectively), 
LHB p.W28R (p=0.956 and 
p=0.372, respectively) and 
LHB p.I35T (p=0.956 and 
p=0.372, respectively).
Table 1. Genotype frequencies SNP Allele Patients (%) Hardy-Weinberg equilibrium Chi-square 
FSHR p.A307T rs6165 
A/A 6 (16.67%) 0.999 0.422 A/T 18 (50.00%) T/T 12 (33.33%) 
FSHR p.N680S rs6166 
S/S 6 (16.67%) 0.999 0.279 S/N 18 (50.00%) N/N 12 (33.33%) 
LHB p.W28R rs1800447 
W/W 23 (63.89%) 0.570 0.009 W/R 13 (36.11%) R/R 0 (0%) 
LHB p.I35T rs34349826 
I/I 23 (63.89%) 0.570 NA I/T 13 (36.11%) T/T 0 (0%)  
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The total r-FSH dosage, although not normally distributed, did not differ among genotypes considering each genotype, such as FSHR p.A307T (p=0.783), FSHR p.N680S 
(p=0.783), LHB p.W28R (p=0.471) and LHB p.I35T (p=0.471). The response to FSH treatment 
was evaluated by the number of retrieved oocytes, which did not differ among genotypes, 
considering FSHR p.A307T (p=0.975), FSHR p.N680S (p=0.975), LHB p.W28R (p=0.709) and 
LHB p.I35T (p=0.709). Moreover, no differences were observed between women showing 
heterozygosity in all SNPs (p=0.796).
SNP genotyping
Four SNPs were genotyped and their allele frequencies were shown in Table 1. Genotypic 
distribution of polymorphisms was consistent with the Hardy-Weinberg equilibrium. No 
differences were observed when comparing FSHR p.A307T and FSHR p.N680S SNPs to 
general population using the International HapMap project. Conversely, LHB p.W28R SNP 
frequency significantly differed from that of general population (p=0.009), even if the only 
data available in literature refer to Utah residents with Northern and Western European 
origin. Concerning LHB-I35T SNP frequency, no data in the general population were available. 
The most frequent haplotype, with a cumulative frequency of 52.24%, was the following: 
FSHR p.A307T-p.S680N, p.T307-p.N680, LHB p.W28-p.I35, p.W28R-p.I35T.
Genotype distributions and combinations found in the group of patients studied are 
shown in Fig. 1. According to genotype frequencies, four models were generated: codominant, dominant, recessive and over-dominant.
Haplotype analysis: clinical characteristics, oocyte retrieval and zygote numbers
No significant differences among haplotypes were found for age (p=0.110), BMI (p=0.089) and r-FSH dosage (p=0.490). The number of arrested metaphase I (MI) oocytes retrieved was 
Fig. 1. Schematic representation of the dis-
tribution and combination of the genotypes 
which have been the object of the reported study.
Table 2. Correlation analysis of women’s clinical parameters 
    BMI Total oocytes MI oocytes Zygotes Embryos Embryos transferred Age (years) Spearman correlation index -0.046 -0.536 -0.212 -0.402 -0.291 -0.031   p-value 0.810 0.001 0.237 0.020 0.107 0.864   n 30 33 33 33 32 33 BMI (kg/m2) Spearman correlation index   0.009 0.013 -0.035 -0.030 0.033   p-value   0.961 0.946 0.855 0.876 0.862   n   30 30 30 30 30 Total oocytes (n) Spearman correlation index     0.536 0.461 0.261 0.042   p-value     0.001 0.007 0.149 0.815   n     33 33 32 33 MI oocytes (n) Spearman correlation index       0.320 0.186 0.137   p-value       0.070 0.309 0.448   n       33 32 33 Zygotes (n) Spearman correlation index         0.615 0.187   p-value         0.000 0.298   n         32 33 Embryos (n) Spearman correlation index           0.292   p-value           0.105   n           32  
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significantly different considering all SNPs evaluated. In particular, the highest number of MI 
oocytes was obtained when the following haplotypes were found: FSHR p.A307T-p.N680S, 
p.A307-S680, LHB p.W28R-p.I35T, p.R28-T35 (3.77; 95% CI: 1.63 – 5.92, p=0.002). More in 
detail, the highest number of MI oocytes was retrieved when a heterozygous haplotype was 
present in both LHB p.W28R and LHB p.I35T (2.10; 95% CI: 0.14 – 4.05, p=0.044). Similarly, 
the number of recorded zygotes were the highest in the same haplotypes: FSHR p.A307T-p.
N680S, p.A307-S680, LHB p.W28R-p.I35T, p.R28-T35 (1.85; 95% CI: 0.09 – 3.62, p=0.047).
Haplotype analysis: gene expression, apoptosis and pAKT levels in cumulus cells
After oocyte pick-up and decoronization, the pool of cumulus cells obtained from mini-
mum six oocytes for each patient was submitted to evaluation of the expression levels of 
genes encoding for EGFR, EGFR ligands and gonadotropin receptors. In addition, their DFI, 
and both cleaved caspase-3 and pAKT accumulation were estimated.
The expression of EGFR was significantly different considering the haplotypes of 
all SNPs evaluated. In particular, the highest expression was found when the following 
haplotypes were found: FSHR p.A307T-p.N680S, p.T307-N680, LHB p.W28R-p.I35T, p.R28-p.
T35 (0.18; 95% CI: 0.03 – 0.34, p=0.025). Moreover, the lowest levels were found when the 
following haplotype was present: FSHR p.A307T-p.N680S, p.A307-S680, LHB p.W28R-p.
I35T, p.R28-T35 (-0.17; 95% CI: -0.034 – -0.01, p=0.049).
The expression of AREG was significantly different considering the haplotypes of 
all SNPs evaluated. In particular, the highest expression was found when the following 
haplotypes were found: FSHR p.A307T p.N680S, FSHR p.A370-S680, LHB p.W28R p.I35T and 
LHB p.R28-p.T35 (3588.96; p<0.001). More in detail, the expression of AREG was highest in 
the recessive model (T/T-A/T vs. A/A) of FSHR p.A307T (4066.07; 95% CI: 663.44 – 7468.70, 
p=0.026), as well as in the recessive model (N/N-S/N vs. S/S) of FSHR p.N680S (4066.07; 
95% CI: 663.44 – 7468.70, p=0.026).
No significant differences among models were found for expression of LHCGR (p=0.059), 
FSHR (p=0.280) and EREG (p=0.074).
The percentage of apoptotic cells, as evaluated by DFI via TUNEL assay, was not 
significantly different among haplotypes (p=0.099). However, the highest percentage of 
apoptotic cells (11.06; 95% CI: 2.54-19.58, p=0.016) was found in the over-dominant model 
for both FSHR p.A307T (T/T-A/A vs. A/T) and FSHR p.N680S (N/N-S/S vs. S/N).
Fig. 2. (A) TUNEL assay. Fluorescent 
micrographs of representative fields showing cumulus cells derived from 
oocytes of patients with double 
heterozygosis (A1-A3) and with 
all other genotypic combinations 
(A4-A6). DNA fragmentation detec-
tion (A1 and A4). Nuclei stained 
with propidium iodide (A2 and A5). 
Merge of green and red fluorescence 
(A3 and A6). Bar 20 µM.(B) Immu-
nofluorescence detection of cleaved 
caspase-3 protein. Fluorescent mi-
crographs of representative fields showing cumulus cells derived from 
oocytes of patients with double het-
erozygosis (B1-B3) and with all oth-
er genotypic combinations (B4-B6). 
Cleaved caspase-3 protein detection 
(B1 and B4). Nuclei stained with Hoechst 33342 (B2 and B5). Merge of green and blue fluorescence (B3 and 
B6). Bar 20 µM.
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The percentage of cleaved caspase-3 was significantly different considering the 
haplotypes of all SNPs evaluated. In particular the highest values were found when the 
following haplotypes were found: FSHR p.A307T-p.N680S, FSHR p.A307-S680, LHB p.W28R-p.
I35T, LHB p.R28-p.T35 (2.74; 95% CI: 0.75-4.72; p=0.010). More in detail, the percentage of 
cleaved caspase-3 was highest in the dominant model (T/T vs. A/T-A/A) of FSHR p.A307T 
(1.87; 95% CI: 0.24-3.50, p=0.031), as well as in the dominant model (N/N vs. S/N-S/S) of 
FSHR p.N680S (1.87; 95% CI: 0.24-3.50, p=0.031).
No significant differences among models were found for oocyte number (p=0.140) and 
pAKT intracellular accumulation (p=0.160).
Correlation analysis
As reported in Table 2, considering the clinical parameters, women’s age showed a 
significant inverse correlation to total oocytes retrieved (p=0.001) while the number of total 
oocytes was directly related to that of MI oocytes (p=0.001) and of zygote number (p=0.007). 
Moreover, zygote number was directly related to embryo number (p<0.001).
The number of apoptotic cells was directly related to FSHR and EREG expression (p<0.001 and p=0.010, respectively) (Table 3). The number of oocytes was directly related to LHCGR expression (p=0.049) and to pAKT accumulation (p=0.036) (Table 3). On the 
contrary, the amount of cleaved caspase-3 was not related to the expression of the receptor 
genes evaluated (Table 3). Considering gene expression levels, LHCGR was directly related to 
EGFR (p<0.001) whereas FSHR was directly related to EREG (p<0.001), EGFR (p<0.001) and 
AREG (p=0.040) (Table 3).
When matching all these parameters together, as reported in Table 4, the number of 
MI oocytes showed a significant positive correlation to the amount of cleaved caspase-3 (p=0.046), the percentage of TUNEL-positive cells (p=0.014), FSHR expression (p=0.045) and EREG expression (p=0.010). In addition, the expression of LHCGR showed significant 
negative correlation to both zygotes (p=0.048) and embryo number (p=0.037).
Table 3. Correlation analyses of gene expression of cellular data 
    Cleaved Caspase-3 (%) pAKT Oocytes (n) LHCGR FSHR EREG EGFR AREG TUNEL positive cells (%) Spearman correlation index 0.433 -0.150 0.036 0.034 0.826 0.451 0.043 -0.038   p-value 0.0112 0.396 0.843 0.855 0.000 0.010 0.824 0.838   n 33 34 33 31 26 32 30 32 Cleaved Caspase-3 (%) Spearman correlation index   0.036 0.194 -0.071 -0.026 0.342 0.070 -0.025   p-value   0.840 0.279 0.706 0.898 0.055 0.713 0.896   n   34 33 31 26 32 30 31 pAKT Spearman correlation index     0.340 0.277 -0.023 -0.026 -0.018 0.125   p-value     .036 0.125 0.911 0.888 0.924 0.495   n     34 32 27 33 31 32 Oocytes (n) Spearman correlation index       0.354 0.214 0.013 0.151 -0.154   p-value       0.049 0.293 0.942 0.426 0.409   n       31 26 32 30 31 LHCGR Spearman correlation index         0.451 0.128 0.647 -0.212   p-value         0.063 0.484 0.000 0.252   n         27 32 31 31 FSHR Spearman correlation index           0.900 0.742 0.659   p-value           0.000 0.000 0.040   n           27 27 26 EREG Spearman correlation index             0.038 0.269   p-value             0.838 0.137   n             31 32 EGFR Spearman correlation index               0.276   p-value               0.140   n               30  
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Finally, we focused our atten-
tion on the differences between 
women with double heterozy-
gosis, i.e. on both FSHR and LHB 
(5/13.89%), and the rest of the 
patients analyzed (31-86.11%). 
As shown in Table 5, age and BMI 
were not significantly different 
between these two further sub-
groups. As regards the endpoints, 
the results obtained with TUNEL assay and immunostaining of 
cleaved-caspase-3 were signifi-
cantly different between groups 
(see panels in fig.2), whereas 
pAKT and the oocyte number did not differ. Noteworthy, gene 
expression was significantly dif-
ferent between groups for LHGR, 
FSHR, EREG and EGFR, but not for 
AREG.
Table 4. Global correlation analysis 
    pAKT Cleaved Caspase-3 (%) TUNEL positive cells (%) AREG LHCGR FSHR EREG EGFR Age (years) Spearman correlation index -0.216 0.042 -0.183 0.353 -0.062 -0.011 -0.240 0.049   p-value 0.213 0.812 0.301 0.055 0.738 0.955 0.179 0.793   n 33 32 32 32 32 27 33 31 BMI (kg/m2) Spearman correlation index -0.106 -0.235 -0.171 -0.004 0.126 0.230 0.140 0.174   p-value 0.577 0.219 0.374 0.985 0.515 0.280 0.462 0.376   n 30 29 29 29 29 24 30 28 total oocytes (n) Spearman correlation index  -0.140 0.135 0.199 -0.086 0.155 0.101 0.098 -0.018   p-value 0.437 0.461 0.275 0.640 0.397 0.616 0.588 0.924   n 33 32 32 32 32 27 33 31 MI oocytes (n) Spearman correlation index -0.240 0.262 0.430 0.081 0.253 0.732 0.530 -.160   p-value 0.178 0.046 0.014 0.659 0.196 0.045 0.010 0.389   n 33 32 32 32 32 27 33 31 Zygotes (n) Spearman correlation index 0.229 0.015 -0.061 -0.093 -0.551 0.079 -0.041 -0.234   p-value 0.200 0.934 0.741 0.611 0.048 0.694 0.819 0.205   n 33 32 32 32 32 27 33 31 Embryos (n) Spearman correlation index 0.098 0.032 0.025 -0.144 -0.375 0.277 -0.026 -0.018   p-value 0.595 0.864 0.894 0.438 0.037 0.125 0.888 0.924   n 32 31 31 31 31 26 32 30  
Table 5. Correlation analysis in women showing double hetero-
zygosis vs. all other combinations  Double heterozygosis All other combinations p-value Age (years) 34.80+2.95 34.13+2.45 0.586 BMI (kg/m2) 21.03+2.34 22.22+3.09 0.468 Total oocytes (n) 11.00+6.63 8.63+2.63 0.178 MI oocytes (n) 6.5+4.04 1.38+2.13 <0.001 Zygotes (n) 4.25+3.10 5.03+1.82 0.464 Embryos (n) 3.25+2.63 3.54+1.10 0.681 Cleaved caspase-3 (%) 6.94+2.30 3.98+2.24 0.011 TUNEL positive cells (%) 34.19+19.72 12.56+9.64 <0.001 pAKT (x 106) 51.71+54.98 48.75+25.00 0.841 AREG 966.76+1894.58 833.71+4038.49 0.949 LHGR 0.99+0.85 0.30+0.23 0.001 FSHR 0.56+0.08 0.01+0.01 0.005 EREG 1.02+1.49 0.14+0.13 0.002 EGFR 0.69+0.27 0.45+0.16 0.026   
 Multivariate regression analyses
Considering a single gene expression as dependent variable and the other data available 
as independent variables, the following models were generated (p<0.001). FSHR expression 
was predicted by those of EREG (p=0.021) and EGFR (p=0.040). EREG expression was 
predicted by those of AREG (p=0.039) and FSHR (p=0.021). AREG expression was predicted 
by that of EREG (p=0.039).
Considering the percentage of apoptotic cells as dependent variable and the other data 
available as independent variables, one model was generated (p=0.001). In particular, the 
number of apoptotic cells expression was predicted by the percentage of cleaved caspase-3 (p=0.011).
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No significant models were generated considering the expression of LHCGR (p = 0.104) and EGFR (p=0.094), as well as the accumulation of cleaved caspase-3 (p=0.271) and pAKT (p=0.950) and the number of oocytes number (p=0.575) as dependent variables.
DiscussionIt is known that the FSHR and LHB variants under study are differently distributed in 
the population. In particular, the T/N and A/S SNPs of FSHR are more frequent and account 
for 60 and 40%, respectively, differently from the rarer A/N and T/S variants which are 
found sporadically and restricted within specific ethnical groups [28]. Also the v-βLH variant of LHB is widely diffused with a maximum incidence in Northern Finland population 
(41.9%) and a carrier frequency of about 14% in Italy where this study was carried out 
[29]. In vitro functional analyses have shown that the FSHR isoforms are endowed with 
equivalent FSH-binding and cAMP-producing activity, differently from v-βLH variant that, 
if compared with wild type LH, displays enhanced bioactivity in vitro and lower half-life in 
vivo which may be compensated by the higher basal activity of its gene promoter [30-32]. 
Studies focused on the possible relationship between either polymorphism and ovarian 
markers have shown a different response to ovarian stimulation by carriers of FSHR SNPs. 
In particular, Ser680 variant is associated to increased resistance of granulosa cells to FSH 
action, enhanced levels of basal FSH and the need of higher doses of FSH administration 
to obtain a good response in terms of follicular growth when the patients undergo FIVET. 
The phenotypic Asn680 polymorphism, on the contrary, confers to carriers an advantage 
in terms of ovarian responsivity to exogenous FSH, being associated with low basal FSH 
levels and a better response to exogenous FSH administration, thereby resulting in a higher 
percentage of clinical pregnancies after embryo transfer [33-36]. The polymorphisms in 
positions 307 and 680 appear to be correlated also with the degree of severity of iatrogenic 
ovarian hyperstimulation syndrome, and the presence of Asn680 genotype may increase the 
risk of developing the pathology due to excessive FSH stimulation [37]. Regarding the LHB 
variant, in the past two decades several studies have found a correlation between v-LHβand 
both fertility and menstrual problems. More recently, Alviggi et al [8]. have confirmed 
that v-LHβpolymorphism produces a less active form of the hormone which is not able to support satisfactorily FSH activity during controlled ovarian stimulation, and that the 
v-LHβ carriers experience a considerable decrease of the number of transferred embryos, 
thereby highlighting the essential role of LH/FSH cooperation in the latest stages of follicle maturation.
In our study, we have analyzed the expression of selected markers of oocyte competence 
and apoptosis-linked cellular features in cumulus cells obtained from follicles of women 
bearing polymorphisms in hormone (LHB) and hormone receptor (FSHR) genes. Among the marker genes tested, EGFR appears to undergo the more varying modifications with 
respect to the specific FSHR SNP, when coupled to p.R28-p.T35 LHB aplotype, being up-regulated in p.T307-N680 carriers and down-regulated in p.A307-S680 carriers, whereas 
AREG expression was always found increased in the recessive models of FSHR. It is known 
that FSH triggers the expression of both EGFR, thereby stimulating EGF sensitivity, and 
LHCGR which, in turn, elicits the production of the EGF-related peptides, such as AREG 
and EREG, and the accumulation of EGFR on the plasmalemma of granulosa cells [38, 39]. 
In the mouse, the LH-mediator AREG is responsible of the expression of several genes 
controlling follicular growth and steroidogenesis and also of its own synthesis by paracrine 
stimulation [40]. Similarly, AREG has been found to induce follicle maturation in humans 
[41] and its protective anti-apoptotic effect has been acknowledged in diverse human cell 
models (e.g [42, 43].). Therefore, consistent with the observed concomitant changes of the 
expression levels of most marker genes analyzed, it is plausible that the genetic alteration of FSHR and/or LHB genes may lead to perturbations of the signaling network programmed to granulosa cell survival and follicle development, ultimately altering oocyte quality via a 
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failure in the synchronization of nuclear and cytoplasmic maturity. This hypothesis is further 
corroborated by results obtained testing the survival/apoptosis markers. Previous data had 
shown DNA fragmentation in human unfertilized oocytes after ICSI, and the positivity to 
caspase-3 immunoassay suggested the occurrence of apoptosis. The high percentage of 
unfertilized oocytes bearing DNA fragmentation was correlated with fertilization failure 
[9]. In addition, Ruvolo et al [20]. demonstrated that preservation of cumulus cells from 
apoptotic processes inhibited the onset of programmed death in the oocytes; hence, the 
apoptosis rate in cumulus cells was used as an indicator of oocyte quality. More recently, 
the occurrence of the apoptotic pathway was analyzed in cumulus cells of single oocytes, 
focusing on the ability of the embryo to reach the blastocyst stage. The obtained data showed 
that in these cells the apoptosis rate was significantly lower and the pAKT/TUNEL ratio was 
higher than in cumulus cells of arrested embryos, indicating a reverse correlation between 
DNA fragmentation and pAKT accumulation. These two parameters were suggested to be 
molecular markers of oocyte competence, to be evaluated as a prognostic pattern of blastocyst 
formation [44]. In the present study, the percentage of TUNEL-positive cells and, more 
prominently, the quantitation of cleaved caspase-3 appear to be the more robust markers to 
predict low developmental potential of the oocyte. These two parameters, in fact, appear to 
be consistently associated with the number of MI oocytes, i.e. those lacking germinal vesicle 
and polar body; interestingly, TUNEL positivity was also significantly correlated with FSHR and EREG up-regulation in cumulus cells, and this result may be interpreted as an attempt 
of granulosa cells to oppose to the onset of programmed cell death, although with no final 
positive outcome. On the other hand, the estimation of the amount of  active AKT appeared 
not to be a significant marker in the model system under study.
It is worth mentioning that, to the best of our knowledge, our study represents the first 
report in which carriers of double heterozygosis were included and analyzed. Interestingly, when these women were compared to the rest of the patients a higher level of apoptosis in 
terms of both DFI and amount of active caspase-3 has been observed in cumulus cells. The 
analysis of clinical data between this group and the other genotypic combinations showed 
also statistically significant differences concerning the prominent increase of the number of 
immature oocytes in metaphase I, and the overexpression of EGFR, EREG, FSHR and LHCGR 
as molecular markers. The reasons for expression specificity of EGF-like peptides (i.e. EREG and not AREG up-regulation as in the analysis of the whole group of patients) is unclear at 
present but may reflect non-redundant biological roles played by AREG and EREG in the 
ovarian tissue, as suggested by [45, 46] in other histotypes, which are still to be elucidated. Nonetheless, if this result is further validated, EREG expression level may be considered a 
specific molecular signature associated to the state of double heterozygous carrier. In light 
of the present data, we expect that patients with double heterozygosity will produce oocytes with a reduced competence after ovarian stimulation with r-FSH, and therefore these results 
could be used to define personalized stimulation protocols in ART programs, with the final 
aim of increasing the success rate of ICSI procedures in accordance with the polymorphic condition of the individual patient.
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